Immunogenicity and safety of a nine-valent human papillomavirus vaccine in women 27-45 years of age compared to women 16-26 years of age: An open-label phase 3 study

Joura, Elmar A.; Ulied, Angels; Vandermeulen, Corinne; Rua Figueroa, Milagrosa; Seppa, Ilkka; Hernandez Aguado, Juan Jose; Ahonen, Anitta; Reich, Olaf; Virta, Miia; Perino, Antonino; Peris Tuser, Merce; Peters, Klaus; Origoni, Massimo; Raspagliesi, Francesco; Tjalma, Wiebren A. A.; Tummers, Philippe; Woelber, Linn; Nieminen, Pekka; van Damme, Pierre; Sehouli, Jalid; Fiol Ruiz, Gabriel; Brucker, Sara; Fehm, Tanja; Cheon, Kyeongmi; Rawat, Sonali; Luxembourg, Alain; Wittke, Frederick

Immunogenicity and safety of a nine-valent human papillomavirus vaccine in women 27-45 years of age compared to women 16-26 years of age: An open-label phase 3 study

Author:

Joura, Elmar A.; Ulied, Angels; Vandermeulen, Corinne; Rua Figueroa, Milagrosa; Seppa, Ilkka; Hernandez Aguado, Juan Jose; Ahonen, Anitta; Reich, Olaf; Virta, Miia; Perino, Antonino; Peris Tuser, Merce; Peters, Klaus; Origoni, Massimo; Raspagliesi, Francesco; Tjalma, Wiebren A. A.; Tummers, Philippe; Woelber, Linn; Nieminen, Pekka; van Damme, Pierre; Sehouli, Jalid; Fiol Ruiz, Gabriel; Brucker, Sara; Fehm, Tanja; Cheon, Kyeongmi; Rawat, Sonali; Luxembourg, Alain; Wittke, Frederick

Tübinger Autor(en):

Brucker, Sara

Published in:

Vaccine (2021), Bd. 39, H. 20, S. 2800-2809

Verlagsangabe:

Elsevier Sci Ltd

Language:

English

Full text:

http://dx.doi.org/10.1016/j.vaccine.2021.01.074

ISSN:

1873-2518